New drug treatment regimen shows promise for patients with lupus
The results of a randomised controlled trial, published in Annals of Internal Medicine, found that a new drug treatment regimen – using belimumab soon after rituximab – reduced a disease-related au…
03/11/2021 | Clinical trials, Inflammation and chronic disease